Celleration to Present at PiperJaffray 20^th Annual Health Care Conference

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Celleration, Inc., developer of the patented MIST Therapy® System, an innovative device that uses ultrasound to heal wounds, announced today that the company will present at the PiperJaffray 20^th Annual Health Care Conference on Wednesday, December 3, 2008. The two-day conference takes place at the New York Palace in New York City.

Kevin Nickels, President and Chief Executive Officer, will provide a company presentation to conference attendees at 10:10 a.m. EST. His presentation will include an overview of Celleration, its core technology, a market overview and future plans for the company.

About Celleration, Inc.

Celleration, Inc., a privately held medical device company, was founded in 1999 to develop and commercialize its proprietary therapeutic ultrasound platform. The patented MIST Therapy^® System utilizes low-intensity ultrasonic sound waves to produce an energized mist of sterile saline in a non-contact fashion. The MIST Therapy^® System is a painless, non-contact ultrasound device used to promote wound healing through cellular stimulation while removing bacteria, allowing clinicians to heal wounds faster. Celleration has over 14 peer-reviewed clinical studies in greater than 540 patients demonstrating superior healing rates with the MIST Therapy^® System in chronic wounds. (www.celleration.com)